Geneva, Switzerland, April 26, 2021 - Addex Therapeutics Ltd (SIX: ADXN and Nasdaq: ADXN), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, announced today that Tim Dyer, Chief Executive Officer, will present at the 4ᵗʰ Annual Neuroscience Innovation Forum (April 26 - 30, 2021).

Read more here:
Addex to Participate at the 4ᵗʰ Annual Neuroscience Innovation Forum

Related Post

Leave a comment

Your email address will not be published. Required fields are marked *


Refresh